+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Personalized Medicine In Oncology"

From
From
From
From
From
Genomics Market Report and Forecast 2025-2034 - Product Thumbnail Image

Genomics Market Report and Forecast 2025-2034

  • Report
  • June 2025
  • 400 Pages
  • Global
From
From
Pyrosequencing Market Report and Forecast 2024-2032 - Product Thumbnail Image

Pyrosequencing Market Report and Forecast 2024-2032

  • Report
  • August 2024
  • 200 Pages
  • Global
From
Personalised Medicine Market Report and Forecast 2024-2032 - Product Thumbnail Image

Personalised Medicine Market Report and Forecast 2024-2032

  • Report
  • July 2024
  • 200 Pages
  • Global
From
From
From
Oncology Drug Market - Forecasts from 2025 to 2030 - Product Thumbnail Image

Oncology Drug Market - Forecasts from 2025 to 2030

  • Report
  • June 2025
  • 141 Pages
  • Global
From
Pituitary Cancer Market in the Netherlands - Product Thumbnail Image

Pituitary Cancer Market in the Netherlands

  • Report
  • May 2026
  • 201 Pages
  • Netherlands
From
Melanoma Cancer Market in China - Product Thumbnail Image

Melanoma Cancer Market in China

  • Report
  • May 2026
  • 162 Pages
  • China
From
Melanoma Cancer Market in South Africa - Product Thumbnail Image

Melanoma Cancer Market in South Africa

  • Report
  • May 2026
  • 164 Pages
  • South Africa
From
Pituitary Cancer Market in China - Product Thumbnail Image

Pituitary Cancer Market in China

  • Report
  • May 2026
  • 202 Pages
  • China
From
Hyperthermia Cancer Treatment Market in Japan - Product Thumbnail Image

Hyperthermia Cancer Treatment Market in Japan

  • Report
  • January 2026
  • 150 Pages
  • Japan
From
Neoantigen Targeted Therapy Market in Germany - Product Thumbnail Image

Neoantigen Targeted Therapy Market in Germany

  • Report
  • December 2025
  • 150 Pages
  • Germany
From
Loading Indicator

Personalized Medicine in Oncology is a field of medicine that uses genomic information to tailor treatments to individual patients. This approach is based on the idea that each patient's cancer is unique and requires a personalized approach to treatment. Genomics is used to identify the genetic mutations that are driving the cancer, and then treatments are tailored to target those mutations. This approach has the potential to improve outcomes and reduce side effects, as treatments are more targeted and tailored to the individual patient. Companies in the Personalized Medicine in Oncology market include Illumina, Thermo Fisher Scientific, QIAGEN, Agilent Technologies, and PerkinElmer. Show Less Read more